Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$1.66 - $2.31 $23,787 - $33,102
14,330 Added 17.84%
94,671 $210,000
Q2 2023

Aug 07, 2023

SELL
$1.61 - $1.96 $383 - $466
-238 Reduced 0.3%
80,341 $149,000
Q1 2023

May 02, 2023

SELL
$1.8 - $2.83 $82,980 - $130,463
-46,100 Reduced 36.39%
80,579 $156,000
Q4 2022

Jan 30, 2023

BUY
$2.05 - $5.5 $850 - $2,282
415 Added 0.33%
126,679 $312,000
Q3 2022

Nov 08, 2022

BUY
$0.94 - $5.99 $29,200 - $186,073
31,064 Added 32.63%
126,264 $625,000
Q2 2022

Aug 04, 2022

BUY
$3.2 - $5.69 $304,640 - $541,688
95,200 New
95,200 $446,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.